Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait

Journal of Medical Virology

Volumn 83, Issue 3, 2011, Pages 453-460

  Al Awadhi, Rana ^a   Chehadeh, Wassim ^a   Kapila, Kusum ^a,b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

Age specific distribution; HPV infection; Normal cervical cytology; PCR based sequencing

Indexed keywords

GENOMIC DNA; VIRUS DNA; WART VIRUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; DNA EXTRACTION; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION SENSITIVITY; INTRAUTERINE CONTRACEPTIVE DEVICE; KUWAIT; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SAMPLE SIZE; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; KUWAIT; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; VAGINAL SMEARS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 78851469941     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21981     Document Type: Article

References (37)

1. Abdel Aziz M, Abdel Aziz M, Atta H, Shaker O, Abdel Fattah M, Mohsen G, Ahmed H, El Derwi D. 2006. Screening for human papillomavirus in Egyptian women by the second-generation hybrid capture (HC II) test. Med Sci Monit 12: MT43-MT49.
2. Al-Awadhi R, Al-Ramadan BA, George SS, Sharma PN, Kapila K. 2010. Gynecologic infections seen in cervical smears in Kuwait. Acta Cytol 54: 50-54.
3. Altman DG. 1999. Practical statistics for medical research. 2nd edition. Boca Raton: Chapman and Hall/CRC, pp. 48-71.
4. Annual Statistical Abstract. 2007. Central statistical office. State of Kuwait. 44th edition. Chapter 3. pp. 41-57.
5. Cervarix Adjuvant. 2007. Cervarix Adjuvant System Effective for 5+ Years. Vaccine Rx. April 18, 2007. Retrieved 2007-04-19.
6. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders P, Vaccarella S, Anh P, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJM, Franceschi S. IARC HPV prevalence survey study group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence survey: A pooled analysis. Lancet 366: 991-998.
7. Coker Al, Sanders LC, Bond SM, Gerasimova T, Pirisi L. 2001. Hormonal and barrier methods of contraception, oncogenic human papillomavirus and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 10: 441-449.
8. de Roda Husman AM, Walboomers JMM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3' with adjacent highly concerved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062.
9. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Manuz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7: 453-459.
10. Dobec M, Bannwart F, Kaeppeli F, Cassinotti P. 2009. Automation of the linear array HPV genotyping test and its application for routine typing of human papiilomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. J Clin Virol 45: 23-27.
11. Dursun P, Senger S, Arslan H, Kuscu E, Ayhan A. 2009. Human papillomavirus (HPV) prevalence and types among Turkish women at gynecology outpatient unit. BMC Infect Dis 9: 191-197.
12. Franceschi S, Herrero R, Clifford GM, Snijders P, Arslan A, Anh P, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Meijer CJM, Munoz N. IARC HPV prevalence survey study group. 2000. Variation in the age specific curve of human papillomavirus prevalence in women worldwide. Int J Cancer 119: 2677-2684.
13. Gazzaz F. 2007. Molecular testing of human papillomavirus in cervical specimens. Saudi Med J 28: 1810-1818.
14. George SS, Luthra SS, Chishti M, Shaheen AA, George J. 2000. Distribution of human papilloma viruses in women. Med Princ Pract 9: 106-112.
15. Ghaffari S, Sabokbar T, Mallahajian H, Dastan J, Ramezanzadeh F, Ensani F, Yarandi F, Mousavi-Jarrahi Mohagheghi M, Moradi A. 2006. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 7: 529-532.
16. Gitsch G, Kainz C, Studnicka M, Reinthaller A, Tatra G, Breitenecker G. 1992. Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia. Arch Gynecol Obstet 252: 25-30.
17. GlaxoSmithKline Vaccine HPV-007 Study Group. Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, Barbier S, Blatter MM, Chambers C, Ferris D, Gall SA, Guerra FA, Harper DM, Hedrick JA, Henry DC, Korn AP, Kroll R, Moscicki AB, Rosenfeld WD, Sullivan BJ, Thoming CS, Tyring SK, Wheeler CM, Dubin G, Schuind A, Zahaf T, Greenacre M, Sgriobhadair A, 2009. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 374: 1975-1985.
18. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. 1998. Genotyping of 27 human papillomavirus types by using L1 consenus PCR products by a single hybridisation reverse line blot detection method. J Clin Microbiol 36: 3020-3027.
19. Hajjaj AA, Senok AC, Al-Mahmeed AE, Isaa AA, Arzese AR, Botta GA. 2006. Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J 27: 487-491.
20. Hammouda D, Munuz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontaniere B, Snijders P, Meijer C, Fransceschi S. 2005. Cervical carcinoma in Algeria: Human papillomavirus and lifestyle risk factors. Int J Cancer 113: 483-489.
21. Hassen E, Chaieb M, Letaief M, Khairi H, Zakhama A, Remadi S, Chouchane L. 2003. Cervical human papillomavirus infection in Tunisian women. Infection 31: 143-148.
22. Human Papillomavirus (HPV). 2008. Vaccines: Q & A - National Cancer Institute. Retrieved 2008-07-18.
23. Kapila K, George SS, Al-Shaheen A, Al-Ottibi MS, Pathan SK, Sheikh ZA, Haji BE, Mallik MK, Das DK, Francis IM. 2006. Changing spectrum of squamous cell abnormalities observed on Papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period. Med Princ Pract 15: 253-259.
24. Kjær SK, van den Brule A, Bock J, Poll P, Engholm G, Sherman ME, Walboomers JMM, Meijer CJ. 1997. Determination for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smears: Are there different risk profile for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 6: 799-805.
25. Kresge KJ, Jill K. 2006. Cervical cancer vaccines. International AIDS Vaccine Initiative., Retrieved 2006-08-28.
26. Kuwait cancer registry. 2006. State of Kuwait. Ministry of Health. Annual Report 2006.
27. Lum A, Le Marchand L. 1998. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 7: 719-724.
28. Luthra UK, Chishti M, Dey P, Jolly SV, Abdulla M, Das DK, Sugathan TN, Ajrawi MT, George J, George SS, Aziz AA, Al-Juwaiser A, Abdul Karim F, Mallik MK, Sheikh ZA, Khan S. 2002. Performance of monolayered cervical smears in gynecology outpatient setting in Kuwait. Acta Cytol 46: 303-310.
29. Ministry of Planning. 2003. Statistics and Census Sector - Annual Statistical Abstracts, 2003.
30. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA. 2002. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaec Oncol 5: 429-432.
31. Munoz N, Bosch X, de Sanjose S, Herrero R, Castellsague X, Shah K, Snijders P, Meijer C. for the international agency for research on cancer multicenter cervical cancer study group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
32. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley K, Brinton LA, Delgado G, Jones S, Tchabo JG. 1990. Oral contraceptive use, human papillomavirus infection and risk of early cytological abnormalities of the cervix. Cancer Res 1: 4670-4675.
33. Schiffman M, Castle PE. 2003. Human papillomavirus: Epidemiology and public health. Arch Pathol Lab Med 127: 930-934.
34. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370: 890-897.
35. Speich N, Schmitt C, Bollmann R, Bollmann M. 2004. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: Genotype spectrum of patients from the west German area. J Med Microbiol 53: 125-128.
36. Vandenvelde C, Van Beers D. 1992. Risk factors including the persistence of high-risk genital papillomavirus in the normal cervix. J Med Virol 38: 226-232.
37. zur Hausen H. 1996. Papillomavirus infection - a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78.